AppliGel-G approved for testing in diabetic foot ulcers

Press Release: Royer Biomedical, Inc. receives FDA approval to proceed with Human Testing (IND 111446) on 5/25/2012 for its AppliGel Polymer Drug Delivery System Quote: Royer Biomedical, Inc. (RBI) received FDA approval to proceed with Human Testing of AppliGel-G (Gentamicin) in management of Diabetic Foot Ulcers (DFU).

Continued here:
AppliGel-G approved for testing in diabetic foot ulcers

Related posts:

1. Management of diabetic foot ulcers with a TLC-NOSF wound dressing
2. Management of diabetic foot ulcers with a TLC-NOSF wound dressing
3. Management of diabetic foot ulcers with a TLC-NOSF wound dressing
4. Management of diabetic foot ulcers with a TLC-NOSF wound dressing
5. Cellerate Rx for Diabetic Foot Ulcers